Alison Lawton

Alison Lawton

Patrimonio netto: - $ in data 30/06/2026

63 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Alison Francis Lawton currently works at Dianthus Therapeutics, Inc., as Independent Chairman from 2023, AgBiome INC, as Director from 2021, SwanBio Therapeutics, Inc., as Director from 2021, Bluerock Therapeutics, Inc., as Director, and Cadena Bio, Inc., as President.
Ms. Lawton also formerly worked at Regulatory Affairs Professionals Society, as Chairman & President, Cubist Pharmaceuticals LLC, as Independent Director from 2012 to 2014, CoLucid Pharmaceuticals, Inc., as Director from 2016 to 2017, Spyre Therapeutics, Inc., as Independent Director, Follica, Inc., as Director, Massachusetts Medical Device Industry Council, as Director, Verastem, Inc., as Independent Director from 2012 to 2020, Kaleido Biosciences, Inc., as Director in 2020, Magenta Therapeutics, Inc., as Director from 2017 to 2018, Magenta Therapeutics, Inc., as Independent Director from 2020 to 2021, X4 Pharmaceuticals, Inc., as Independent Director from 2020 to 2025, Genzyme Corp., as Senior Vice President from 2011 to 2012, Aura Biosciences, Inc., as Chief Operating Officer from 2015 to 2017, Parke-Davis & Co. Ltd., as Principal, Genzyme Biosurgery Corp., as General Manager from 2012 to 2013, Sanofi, Inc., as General Manager-Biosurgery, OvaScience, Inc., as Chief Operating Officer from 2013 to 2014, Sanofi-Aventis, Inc., as Head-Genzyme Biosurgery, X4 Pharmaceuticals, Inc., as Chief Operating Officer from 2014 to 2017, BIOSURGERY S.R.L., as Senior Vice President & General Manager, and ProQR Therapeutics NV, as Independent Member-Supervisory Board from 2014 to 2026.
Ms. Lawton received her undergraduate degree from King's College London.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
18/03/2026 0 ( -.--% ) - $ 30/06/2026
21/05/2026 0 ( -.--% ) - $ 30/06/2026

Posizioni attive di Alison Lawton

SocietàPosizioneInizio
DIANTHUS THERAPEUTICS, INC. Presidente 11/09/2023
Presidente -
Direttore/Membro del Consiglio 04/05/2021
Direttore/Membro del Consiglio 19/01/2021
Direttore/Membro del Consiglio -

Precedenti posizioni note di Alison Lawton

SocietàPosizioneFine
PROQR THERAPEUTICS N.V. Direttore/Membro del Consiglio 02/06/2026
X4 PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 09/06/2025
SPYRE THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/02/2024
KALEIDO BIOSCIENCES, INC. Amministratore Delegato 16/06/2020
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Alison Lawton

Formazione di Alison Lawton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

91

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

  1. Mercati
  2. Insiders
  3. Alison Lawton